Literature DB >> 18671317

A bridge between interferon-alpha and tumor necrosis factor in lupus.

Martin Aringer, Mary K Crow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18671317

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

1.  Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Authors:  Juan M Mejia-Vilet; Samir V Parikh; Huijuan Song; Paolo Fadda; John P Shapiro; Isabelle Ayoub; Lianbo Yu; Jianying Zhang; Norma Uribe-Uribe; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

Review 2.  Using genetics to deliver personalized SLE therapy-a realistic prospect?

Authors:  Benjamin Rhodes; Timothy J Vyse
Journal:  Nat Rev Rheumatol       Date:  2010-05-04       Impact factor: 20.543

Review 3.  IL-10 and TNFalpha genotypes in SLE.

Authors:  Patricia López; Carmen Gutiérrez; Ana Suárez
Journal:  J Biomed Biotechnol       Date:  2010-06-21

Review 4.  The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.

Authors:  Consuelo M López de Padilla; Timothy B Niewold
Journal:  Gene       Date:  2015-09-26       Impact factor: 3.688

5.  1.5 Decades Later: Bearing fruits from the ACR/EULAR exchange Program.

Authors:  Randy Q Cron; Hendrik Schulze-Koops
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-04       Impact factor: 3.054

6.  Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.

Authors:  Iain J Abbott; Christina C Chang; Matthew J Skinner; Alison Street; Greg Perry; Catriona McLean; Edwina J Wright; Paul U Cameron
Journal:  J Med Case Rep       Date:  2009-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.